[Congressional Record Volume 161, Number 137 (Tuesday, September 22, 2015)]
[Daily Digest]
[Page D1002]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
(Committees not listed did not meet)
U.S. MIDDLE EAST POLICY
Committee on Armed Services: Committee concluded a hearing to examine 
United States Middle East policy, after receiving testimony from 
General David H. Petraeus, USA (Ret.), former Director, Central 
Intelligence Agency, Commander, International Security Assistance 
Force/Commander, United States Forces Afghanistan, Commander, United 
States Central Command, Commander, Multi-National Forces-Iraq.
NOMINATION
Committee on Foreign Relations: Committee concluded a hearing to 
examine the nomination of Susan Coppedge Amato, of Georgia, to be 
Director of the Office to Monitor and Combat Trafficking, with the rank 
of Ambassador at Large, Department of State, after the nominee, who was 
introduced by Senator Isakson, testified and answered questions in her 
own behalf.
IMPROVING VA ACCOUNTABILITY
Committee on Homeland Security and Governmental Affairs: Committee 
concluded a hearing to examine improving VA accountability, focusing on 
examining first-hand accounts of Department of Veterans Affairs 
whistleblowers, after receiving testimony from Carolyn Lerner, Special 
Counsel, Office of Special Counsel; Linda A. Halliday, Deputy Inspector 
General, Office of Inspector General, Carolyn Clancy, Chief Medical 
Officer, Veterans Health Administration, and Michael Culpepper, Acting 
Director, Office of Accountability Review, all of the Department of 
Veterans Affairs; Brandon W. Coleman Sr., Phoenix Veterans Affairs 
Health Care System, Phoenix, Arizona; Joseph Colon, VA Caribbean 
Healthcare System, San Juan, Puerto Rico; Christopher Shea Wilkes, VA 
Truth Tellers, Shreveport, Louisiana; and Sean Kirkpatrick, Chicago, 
Illinois.
HEALTH INSURANCE INDUSTRY CONSOLIDATION
Committee on the Judiciary: Subcommittee on Antitrust, Competition 
Policy and Consumer Rights concluded a hearing to examine consolidation 
in the health insurance industry and its impact on consumers, including 
S. 2019, to prohibit brand name drug companies from compensating 
generic drug companies to delay the entry of a generic drug into the 
market, after receiving testimony from Mark T. Bertolini, Aetna, Inc., 
Hartford, Connecticut; Joseph Swedish, Anthem, Inc., Indianapolis, 
Indiana; Paul B. Ginsburg, University of Southern California Sol Price 
School of Public Policy Schaeffer Center for Health and Policy 
Economics, Rick Pollack, American Hospital Association, and George 
Slover, Consumers Union, all of Washington, D.C.; and Leemore S. Dafny, 
Northwestern University Kellogg School of Management, Evanston, 
Illinois.
INTELLIGENCE
Select Committee on Intelligence: Committee met in closed session to 
receive a briefing on certain intelligence matters from officials of 
the intelligence community.